An AAV variant selected through NHP screens robustly transduces the brain and drives secreted protein expression in NHPs and mice
- 14 May 2025
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 17 (798) , eadr2531
Abstract
Recent work has shown that prolonged expression of recombinant proteins after adeno-associated virus (AAV)–mediated delivery of gene therapy to long-lived, ventricle-lining ependymal cells can profoundly affect disease phenotypes in animal models of neurodegenerative diseases. Here, we performed in vivo screens of millions of peptide-modified capsid variants of AAV1, AAV2, and AAV9 parental serotypes in adult nonhuman primates (NHPs) to identify capsids with potent transduction of key brain tissues, including ependyma, after intracerebroventricular injection. Through these screens, we identified an AAV capsid, AAV-Ep + , with markedly increased potency in transducing ependymal cells and cerebral neurons in NHPs. AAV-Ep + ’s potency was conserved in three species of NHP, two mouse strains, and human neurons derived from induced pluripotent stem cells. To apply AAV-Ep + to the treatment of ceroid lipofuscinosis type 2 disease, a lysosomal storage disorder caused by loss-of-function mutations in tripeptidyl-peptidase 1 ( TPP1 ), we used the capsid to package the human TPP1 transgene (AAV-Ep + .hTPP1) and delivered the construct by intracerebroventricular injection into mice lacking TPP1 activity. AAV-Ep + provided robust and therapeutically relevant TPP1 protein concentrations in these mice, significantly improving tremor and life span. In NHPs, high cerebrospinal fluid (CSF) TPP1 concentrations were achieved after intracerebroventricular delivery of AAV-Ep + .hTPP1 at a total dose of 1 × 10 12 viral genomes, which was more than 30× lower than previously reported doses in NHPs. These results suggest that AAV-Ep + may be a potent vector for gene therapy applications where CSF protein expression is required.Keywords
This publication has 38 references indexed in Scilit:
- Reproducible Differentiation of Human Pluripotent Stem Cells into Two‐Dimensional Cortical Neuron Cultures with Checkpoints for SuccessCurrent Protocols, 2023
- An ependymal cell census identifies heterogeneous and ongoing cell maturation in the adult mouse spinal cord that changes dynamically on injuryDevelopmental Cell, 2023
- Characterization of AAV-mediated dorsal root ganglionopathyMolecular Therapy - Methods & Clinical Development, 2022
- Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative DiseasesMolecular Neurobiology, 2021
- Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brainNeuroscience Letters, 2018
- Intracerebroventricular Delivery as a Safe, Long-Term Route of Drug AdministrationPediatric Neurology, 2017
- A diffusion tensor MRI atlas of the postmortem rhesus macaque brainNeuroImage, 2015
- Distribution of acid sphingomyelinase in rodent and non-human primate brain after intracerebroventricular infusionExperimental Neurology, 2011
- Gene therapy for lysosomal storage diseasesMolecular Therapy, 2006
- Distribution of extracellular tracers in perivascular spaces of the rat brainBrain Research, 1991